SIRT1 and polycystic ovary syndrome: In this study, We observed that both metformin and empagliflozin can improve the endocrine and metabolic functioning in rats with PCOS‐IR via the AMPK‐SIRT1 pathway which may be the molecular basis for IR in PCOS and may potentially be a therapeutic target.